Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche

Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.

Top View of Samsung BioLogics Plant. (PRNewsFoto/Samsung BioLogics)
Top View of Samsung BioLogics Plant. (PRNewsFoto/Samsung BioLogics)
Top View of Samsung BioLogics Plant. (PRNewsFoto/Samsung BioLogics)
Top View of Samsung BioLogics Plant. (PRNewsFoto/Samsung BioLogics)

Terms of the agreement will not be disclosed, including financial terms and products to be manufactured. "We are pleased to announce this strategic manufacturing relationship with Roche and look forward to delivering best-in-class manufacturing services with the highest global quality standards," said Tae-Han Kim, president and CEO of Samsung BioLogics. "This collaboration with the world's largest biotech company is an important milestone for Samsung as it validates our long term strategy of becoming a leader in biopharmaceutical manufacturing."


About Samsung BioLogics
Samsung BioLogics is a full-service provider of quality-driven contract process development and cGMP manufacturing to the global biopharmaceutical industry. Our facilities are custom designed for monoclonal antibody & recombinant protein production with maximum flexibility. Our one-stop services include cell line generation, process and analytical method development, analytical services, clinical and commercial bulk cGMP manufacturing of drug substance and drug product meeting the highest standards of quality and global regulatory compliance. For additional information about the company, please visit http://www.samsungbiologics.com.


 

 

23.10.2013

Read all latest stories

Related articles

Photo

Deep learning

Samsung: AI develops beyond the breast

Access, accuracy and efficiency are at the core of Samsung’s healthcare strategy, explained Insuk Song, Vice President of Product Planning, Healthcare and Medical Equipment at Samsung Electronics,…

Photo

Automation

Proven Practices for Lab Automation Success

Cost constraints, higher workloads, and a shortage of qualified staff are three distinct market trends driving demand for greater efficiency in the laboratory. The goals of automation are to make…

Photo

Digital

Convincing overall package

The joint practice of Drs. Ulrike and Dieter von der Burg in Münster, Germany, decided on the GU60 digital X-ray system by Samsung Health Medical Equipment (HME) and is very pleased with the image…

Related products

Samsung – GC85A

DR

Samsung – GC85A

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.
Samsung – GM85

Mobile DR

Samsung – GM85

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.
Samsung – HERA W10

Ultrasound

Samsung – HERA W10

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.
Samsung – HM70A with Plus

Ultrasound

Samsung – HM70A with Plus

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.
Samsung – HS30

Ultrasound

Samsung – HS30

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.
Samsung – HS40

Ultrasound

Samsung – HS40

Samsung Electronics Co., Ltd. / Samsung Medison Co., Ltd.